Literature DB >> 16539307

Serum amyloid A, properdin, complement 3, and toll-like receptors are expressed locally in human sinonasal tissue.

Andrew P Lane1, Quynh-Ai Truong-Tran, Allan Myers, Carol Bickel, Robert P Schleimer.   

Abstract

BACKGROUND: There is a growing appreciation of the role that nasal mucosa plays in innate immunity. In this study, the expression of pattern recognition receptors known as toll-like receptors (TLRs) and the effector molecules complement factor 3 (C3), properdin, and serum amyloid A (SAA) were examined in human sinonasal mucosa obtained from control subjects and patients with chronic rhinosinusitis (CRS).
METHODS: Sinonasal mucosal specimens were obtained from 20 patients with CRS and 5 control subjects. Messenger RNA (mRNA) was isolated and tested using Taqman real-time polymerase chain reaction with primer and probe sets for C3, complement factor P, and SAA. Standard polymerase chain reaction was performed for the 10 known TLRs. Immunohistochemistry was performed on the microscopic sections using antibodies against C3.
RESULTS: Analysis of the sinonasal sample mRNA revealed expression of all 10 TLRs in both CRS samples and in control specimens. Expression of the three effector proteins was detected also, with the levels of mRNA for C3 generally greater than SAA and properdin in CRS patients. No significant differences were found in TLR or innate immune protein expression in normal controls. Immunohistochemical analysis of sinonasal mucosal specimens established C3 staining ranging from 20 to 85% of the epithelium present.
CONCLUSION: These studies indicate that sinonasal mucosa expresses genes involved in innate immunity including the TLRs and proteins involved in complement activation. We hypothesize that local production of complement and acute phase proteins by airway epithelium on stimulation of innate immune receptors may play an important role in host defense in the airway and, potentially, in the pathogenesis of CRS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16539307      PMCID: PMC2802262     

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  40 in total

Review 1.  Toll-like receptors and their ligands.

Authors:  G M Barton; R Medzhitov
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

Review 2.  Intestinal epithelial toll-like receptors: to protect. And serve?

Authors:  Andrew T Gewirtz
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

Review 3.  Viral respiratory infections in association with asthma and sinusitis: a review.

Authors:  Scott L Osur
Journal:  Ann Allergy Asthma Immunol       Date:  2002-12       Impact factor: 6.347

4.  Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha.

Authors:  D L Hamilos; D Y Leung; R Wood; D K Bean; Y L Song; E Schotman; Q Hamid
Journal:  Am J Respir Cell Mol Biol       Date:  1996-10       Impact factor: 6.914

Review 5.  Chronic sinusitis and allergic rhinitis: at the nexus of sinonasal inflammatory disease.

Authors:  Jayant M Pinto; Fuad M Baroody
Journal:  J Otolaryngol       Date:  2002-08

6.  Human beta-defensins and toll-like receptors in the upper airway.

Authors:  S Claeys; T de Belder; G Holtappels; P Gevaert; B Verhasselt; P van Cauwenberge; C Bachert
Journal:  Allergy       Date:  2003-08       Impact factor: 13.146

7.  Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein.

Authors:  Matthew J Taylor; Jens U Ponikau; David A Sherris; Eugene B Kern; Thomas A Gaffey; Gail Kephart; Hirohito Kita
Journal:  Otolaryngol Head Neck Surg       Date:  2002-11       Impact factor: 3.497

8.  C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation.

Authors:  P J Daffern; P H Pfeifer; J A Ember; T E Hugli
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

Review 9.  Mediators in nasal polyposis.

Authors:  Claus Bachert; Philippe Gevaert; Gabriele Holtappels; Paul van Cauwenberge
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

10.  Complement factor 3 mediates particulate matter-induced airway hyperresponsiveness.

Authors:  Dianne M Walters; Patrick N Breysse; Brian Schofield; Marsha Wills-Karp
Journal:  Am J Respir Cell Mol Biol       Date:  2002-10       Impact factor: 6.914

View more
  32 in total

Review 1.  Impact of tobacco smoke on chronic rhinosinusitis: a review of the literature.

Authors:  Douglas D Reh; Thomas S Higgins; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2012-06-13       Impact factor: 3.858

Review 2.  Chronic rhinosinusitis and sleep: a contemporary review.

Authors:  Jeremiah A Alt; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2013-08-26       Impact factor: 3.858

Review 3.  A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS).

Authors:  M Mahdavinia; A Keshavarzian; M C Tobin; A L Landay; R P Schleimer
Journal:  Clin Exp Allergy       Date:  2016-01       Impact factor: 5.018

4.  Antisomnogenic cytokines, quality of life, and chronic rhinosinusitis: a pilot study.

Authors:  Jeremiah A Alt; Nathan B Sautter; Jess C Mace; Kara Y Detwiller; Timothy L Smith
Journal:  Laryngoscope       Date:  2013-10-22       Impact factor: 3.325

Review 5.  Pathogenesis of nasal polyposis.

Authors:  K E Hulse; W W Stevens; B K Tan; R P Schleimer
Journal:  Clin Exp Allergy       Date:  2015-02       Impact factor: 5.018

Review 6.  Technical advances in rhinologic basic science research.

Authors:  Murugappan Ramanathan; Justin H Turner; Andrew P Lane
Journal:  Otolaryngol Clin North Am       Date:  2009-10       Impact factor: 3.346

Review 7.  Perspectives on the etiology of chronic rhinosinusitis.

Authors:  Bruce K Tan; Robert P Schleimer; Robert C Kern
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-02       Impact factor: 2.064

8.  Interleukin-17A contributes to the expression of serum amyloid A in chronic rhinosinusitis with nasal polyps.

Authors:  Hongtian Wang; Jing Bai; Minhong Ding; Wenlong Liu; Rui Xu; Jing Zhang; Jianbo Shi; Huabin Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-18       Impact factor: 2.503

Review 9.  Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis.

Authors:  Robert C Kern; David B Conley; William Walsh; Rakesh Chandra; Atsushi Kato; Anju Tripathi-Peters; Leslie C Grammer; Robert P Schleimer
Journal:  Am J Rhinol       Date:  2008-09-10

10.  Epithelial genes in chronic rhinosinusitis with and without nasal polyps.

Authors:  Sara L Richer; Ai Q Truong-Tran; David B Conley; Roderick Carter; David Vermylen; Leslie C Grammer; Anju T Peters; Rakesh K Chandra; Kathleen E Harris; Robert C Kern; Robert P Schleimer
Journal:  Am J Rhinol       Date:  2008 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.